Sunday , 27 September 2020

Tag Archives: Ezetimibe

Simultaneous Estimation Method for the Determination of Rosuvastatin and Ezetimibe from their Combination Tablet Dosage form Using RP-HPLC

S. Mehboob Basha, Shaik Mohmmed Yusuf*, Vummadi Sai Chandana, Bumireddy Pavani, E. Vijay Kumar Department of Pharmaceutical Analysis, Srinivasa Institute of Pharmaceutical Sciences, Proddatur, YSR Kadapa, A.P. India A B S T R A C T Rosuvastatin is an HMG Co-A inhibitor and Ezetimibe is an intestinal cholesterol absorption inhibitor. The combination formulation is used for the treatment of hypercholestrolemia. A ... Read More »

Formulation and Evaluation of Ezetimibe Immediate Release Tablets

B. Venkateswara Reddy*, M. Suresh, K. Navaneetha Department of Pharmaceutics, St. Pauls College of Pharmacy, Turkayamjal, Hayathnagar, R.R.Dist-501510, India A B S T R A C T Ezetimibe is an orally active anti-cholesterol agent, acts by inhibiting the absorption of cholesterol at the brush border of small intestine. The objective of the present study was to formulate and evaluate immediate ... Read More »

A Review on Statin Co-Administration with Ezetimibe or Niacin for the Treatment of Hypercholesterolemia and other Diseases

ABOUT AUTHOR Nutan Kumari*, Dr. B. Srivasatva, Ajay Kumar Tiwari, Renu  Kalyanwat, Vikas Kumar Singh, Ravi R .Parekh   School of Pharmaceutical Sciences Jaipur National University E-mail: nutan216@gmail.com ABSTRACT Hypercholesterolemia disease treatment with HMG-CoA reductase inhibitors has been very successful. There is increasing interest in adding other lipid lowering therapy, primarily as additional therapy onto HMG-CoA reductase therapy. This paper will ... Read More »

Optimization and Evaluation of Immediate Release Tablet in combination of EZETIMIBE and SIMVASTATIN drugs

ABOUT AUTHOR Nutan  Kumari*, Dr. B. Srivasatva, Ajay Kumar Tiwari, Ms. Renu  Kalyanwat School of Pharmaceutical Sciences Jaipur National University E-mail: nutan216@gmail.com ABSTRACT hypercholesterolemia disease treatment with HMG-CoA reductase inhibitors has been very successful.The purpose of this study was to assess the efficacy and safety of ezetimibe administered with simvastatin in patients with primary hypercholesterolemia. This paper will examine two of ... Read More »

Scroll To Top